These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2687767

  • 1. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma.
    Field JK, Spandidos DA, Stell PM, Vaughan ED, Evan GI, Moore JP.
    Oncogene; 1989 Dec; 4(12):1463-8. PubMed ID: 2687767
    [Abstract] [Full Text] [Related]

  • 2. C-erbB-2 expression in squamous cell carcinoma of the head and neck.
    Field JK, Spandidos DA, Yiagnisis M, Gosney JR, Papadimitriou K, Stell PM.
    Anticancer Res; 1992 Dec; 12(3):613-9. PubMed ID: 1377893
    [Abstract] [Full Text] [Related]

  • 3. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M, Mattern J.
    Anticancer Res; 1993 Dec; 13(6A):2021-5. PubMed ID: 8297109
    [Abstract] [Full Text] [Related]

  • 4. Expression of c-erbB-2 gene in human head and neck carcinoma.
    Craven JM, Pavelic ZP, Stambrook PJ, Pavelic L, Gapany M, Kelley DJ, Gapany S, Gluckman JL.
    Anticancer Res; 1992 Dec; 12(6B):2273-6. PubMed ID: 1363518
    [Abstract] [Full Text] [Related]

  • 5. [Oncogenes in squamous epithelial cancers in the area of the head and neck].
    Volling P, Jungehülsing M, Tesch H, Stennert E.
    Laryngol Rhinol Otol (Stuttg); 1988 Apr; 67(4):160-4. PubMed ID: 3386367
    [Abstract] [Full Text] [Related]

  • 6. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
    Akervall J, Bockmühl U, Petersen I, Yang K, Carey TE, Kurnit DM.
    Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
    [Abstract] [Full Text] [Related]

  • 7. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
    Kohler M, Janz I, Wintzer HO, Wagner E, Bauknecht T.
    Anticancer Res; 1989 May; 9(6):1537-47. PubMed ID: 2697181
    [Abstract] [Full Text] [Related]

  • 8. Clinical relevance of oncogene expression in head and neck tumours.
    Field JK, Lamothe A, Spandidos DA.
    Anticancer Res; 1986 May; 6(4):595-600. PubMed ID: 3019219
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas.
    Waitzberg AF, Nonogaki S, Nishimoto IN, Kowalski LP, Miguel RE, Brentani RR, Brentani MM.
    Cancer Detect Prev; 2004 May; 28(3):178-86. PubMed ID: 15225897
    [Abstract] [Full Text] [Related]

  • 10. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
    Frederick MJ, Holton PR, Hudson M, Wang M, Clayman GL.
    Clin Cancer Res; 1999 Feb; 5(2):361-9. PubMed ID: 10037186
    [Abstract] [Full Text] [Related]

  • 11. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
    Giatromanolaki A, Koukourakis MI, Sivridis E, Fountzilas G.
    Anticancer Res; 2000 Feb; 20(2A):997-1004. PubMed ID: 10810387
    [Abstract] [Full Text] [Related]

  • 12. c-fos and c-myc oncoprotein expression in human hepatocellular carcinomas.
    Arbuthnot P, Kew M, Fitschen W.
    Anticancer Res; 1991 Feb; 11(2):921-4. PubMed ID: 1648336
    [Abstract] [Full Text] [Related]

  • 13. Human bronchial epithelial cells transformed by the c-raf-1 and c-myc protooncogenes induce multidifferentiated carcinomas in nude mice: a model for lung carcinogenesis.
    Pfeifer AM, Jones RT, Bowden PE, Mann D, Spillare E, Klein-Szanto AJ, Trump BF, Harris CC.
    Cancer Res; 1991 Jul 15; 51(14):3793-801. PubMed ID: 1712250
    [Abstract] [Full Text] [Related]

  • 14. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
    Mohamed AN, Nakeff A, Mohammad RM, KuKuruga M, al-Katib A.
    Oncogene; 1988 Oct 15; 3(4):429-35. PubMed ID: 3152600
    [Abstract] [Full Text] [Related]

  • 15. High levels of c-myc protein in human breast tumours determined by a sensitive ELISA technique.
    Spandidos DA, Field JK, Agnantis NJ, Evan GI, Moore JP.
    Anticancer Res; 1989 Oct 15; 9(4):821-6. PubMed ID: 2683996
    [Abstract] [Full Text] [Related]

  • 16. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L, Stephenson KK, Ling W, Zuo C, Mukunyadzi P, Suen JY, Hanna E, Fan CY.
    Mod Pathol; 2003 Sep 15; 16(9):944-50. PubMed ID: 13679459
    [Abstract] [Full Text] [Related]

  • 17. [Detection of 8 oncogenes in squamous epithelial cancers of the head and neck].
    Jungehülsing M, Volling P.
    HNO; 1994 May 15; 42(5):280-7. PubMed ID: 8050916
    [Abstract] [Full Text] [Related]

  • 18. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
    Stathopoulos GP, Kapranos N, Manolopoulos L, Papadimitriou C, Adamopoulos G.
    Anticancer Res; 2000 May 15; 20(1A):177-82. PubMed ID: 10769652
    [Abstract] [Full Text] [Related]

  • 19. [Drug resistance, oncogenes, and anti-oncogenes in epithelial tumors].
    Riva-Lavieille C.
    Bull Cancer; 1994 Dec 15; 81 Suppl 2():105s-111s. PubMed ID: 7727855
    [Abstract] [Full Text] [Related]

  • 20. c-myc oncoprotein in bronchial carcinoma: expression in all major morphological types.
    Gosney JR, Field JK, Gosney MA, Lye MD, Spandidos DA, Butt SA.
    Anticancer Res; 1990 Dec 15; 10(3):623-8. PubMed ID: 2164348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.